litlas
ログインアカウント作成

Peter Dreger

1993–2025 年に発表

199
論文数
18,752
被引用数
83
h 指数
191
i10 指数

被引用数

Peter Dreger の年別被引用数1993 年: 被引用 2 件1994 年: 被引用 6 件1995 年: 被引用 19 件1996 年: 被引用 25 件1997 年: 被引用 36 件1998 年: 被引用 23 件1999 年: 被引用 39 件2000 年: 被引用 43 件2001 年: 被引用 23 件2002 年: 被引用 31 件2003 年: 被引用 25 件2004 年: 被引用 34 件2005 年: 被引用 55 件2006 年: 被引用 34 件2007 年: 被引用 36 件2008 年: 被引用 54 件2009 年: 被引用 53 件2010 年: 被引用 59 件2011 年: 被引用 64 件2012 年: 被引用 76 件2013 年: 被引用 72 件2014 年: 被引用 95 件2015 年: 被引用 117 件2016 年: 被引用 127 件2017 年: 被引用 101 件2018 年: 被引用 117 件2019 年: 被引用 423 件2020 年: 被引用 544 件2021 年: 被引用 530 件2022 年: 被引用 504 件2023 年: 被引用 446 件2024 年: 被引用 846 件2025 年: 被引用 457 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,639 件、この内訳の 19%ドイツ: 引用元論文 913 件、この内訳の 10.6%イタリア: 引用元論文 607 件、この内訳の 7%イギリス: 引用元論文 599 件、この内訳の 6.9%フランス: 引用元論文 548 件、この内訳の 6.4%中国: 引用元論文 463 件、この内訳の 5.4%スペイン: 引用元論文 432 件、この内訳の 5%オランダ: 引用元論文 347 件、この内訳の 4%スイス: 引用元論文 245 件、この内訳の 2.8%カナダ: 引用元論文 232 件、この内訳の 2.7%イスラエル: 引用元論文 193 件、この内訳の 2.2%オーストラリア: 引用元論文 185 件、この内訳の 2.2%
0%19%その他 25.8%

機関

分野

  • Medicine82.9%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Immunology and Microbiology5.3%
  • Neuroscience1.7%
  • Psychology1%
  • Computer Science0.6%
  • その他1%

トピック

  • CAR-T cell therapy research9.2%
  • Hematopoietic Stem Cell Transplantation8.9%
  • Lymphoma Diagnosis and Treatment6.5%
  • Acute Myeloid Leukemia Research5.2%
  • Chronic Lymphocytic Leukemia Research4.7%
  • Immune Cell Function and Interaction3.2%
  • その他62.3%

共著者

全論文

検索で開く
  1. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

    著者: Maria‐Luisa Schubert, Michael Schmitt, L. Wang, Carlos A. Ramos, Karin Jordan, Carsten Müller‐Tidow, Peter Dreger - Annals of Oncology 2020 被引用: 487

  2. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

    著者: Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Matthias Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia‐Chi Chang, Lauren McDaniel, Ivonne I. Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphaël Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Michael Wang, Joel G. Turner, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller‐Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav - Nature Medicine 2023 被引用: 226

  3. GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

    著者: Wolfgang Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Wagner-Drouet, Gerald Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glaß, Claudia D. Baldus, Vladan Vučinić, Dimitrios Mougiakakos, Max S. Topp, Matthias Fante, Roland Schroers, Lâle M. Bayir, Peter Borchmann, Veit Buecklein, Christine Hanoun, Simone Thomas, Dietrich W. Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger - Blood 2022 被引用: 211

  4. Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis

    著者: Wolfgang Merkt, Merle Freitag, Maren Claus, Philipp Kolb, Valeria Falcone, Manuel Röhrich, Lea Rodon, Franca Sophie Deicher, Ivana Andreeva, Theresa Tretter, Lars‐Oliver Tykocinski, Norbert Blank, Carsten Watzl, Anita Schmitt, Tim Sauer, Carsten Müller‐Tidow, Markus Polke, Claus Peter Heußel, Peter Dreger, Hanns‐Martin Lorenz, Michael Schmitt - Annals of the Rheumatic Diseases 2023 被引用: 120

  5. Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma

    著者: Frederick L. Locke, Simone Filosto, Justin Chou, Saran Vardhanabhuti, Régis Perbost, Peter Dreger, Brian T. Hill, Catherine J. Lee, Pier Luigi Zinzani, Nicolaus Kröger, Armando López‐Guillermo, Hildegard Greinix, Wangshu Zhang, Gayatri Tiwari, Justin A. Budka, Francesco M. Marincola, Christina To, Mike Mattie, Marco Schupp, Paul Cheng, Adrian Bot, Rhine R. Shen, Davide Bedognetti, Harry Miao, Jérôme Galon - Nature Medicine 2024 被引用: 108

  6. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis

    著者: Thomas Luft, Axel Benner, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Ted Gooley, Brenda M. Sandmaier, Natália Becker, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - The Lancet Haematology 2017 被引用: 246

  7. EASIX and mortality after allogeneic stem cell transplantation

    著者: Thomas Luft, Axel Benner, Tobias Terzer, Sonata Jodele, Christopher E. Dandoy, Rainer Storb, Lambros Kordelas, Dietrich W. Beelen, Ted Gooley, Brenda M. Sandmaier, Mohamed L. Sorror, Markus Zeisbrich, Aleksandar Radujkovic, Peter Dreger, Olaf Penack - Bone Marrow Transplantation 2019 被引用: 160

  8. Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    著者: H. Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Othman Al‐Sawaf, Karl‐Anton Kreuzer, Anna‐Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer - Blood 2023 被引用: 48

  9. Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

    著者: for the European Society for Blood and Marrow Transplantation (EBMT), Rafael F. Duarte, Myriam Labopin, Peter Bader, Grzegorz Basak, Chiara Bonini, Christian Chabannon, Selim Corbacioglu, Peter Dreger, Carlo Dufour, Andrew R. Gennery, Jürgen Kuball, Arjan C. Lankester, Francesco Lanza, Silvia Montoto, Arnon Nagler, Régis Peffault de Latour, John A. Snowden, Jan Styczyński, Ibrahim Yakoub‐Agha, Nicolaus Kröger, Mohamad Mohty - Bone Marrow Transplantation 2019 被引用: 332

  10. Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

    著者: Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke, Uwe Platzbecker, Ruzena Uddin, Kai Hübel, Christof Scheid, Thomas Weber, Marie Robin, Matthias Stelljes, Boris V. Afanasyev, Dominik Heim, Giorgio La Nasa, Francesco Onida, Peter Dreger, Massimo Pini, Stefano Guidi, Liisa Volin, Andreas Guenther, Wolfgang Bethge, Xavier Poiré, Guido Kobbe, Marleen van Os, Ronald Brand, Théo de Witte - Journal of Clinical Oncology 2017 被引用: 249

  11. Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study

    著者: Nico Gagelmann, Gerald Wulf, Johannes Duell, Bertram Glaß, Pearl van Heteren, Bastian von Tresckow, Monika Fischer, Olaf Penack, Francis Ayuk, H. Einsele, Udo Holtick, Julia Thomson, Peter Dreger, Nicolaus Kröger - Blood Advances 2022 被引用: 55

  12. Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

    著者: Mahmoud Elsawy, Julio C. Chávez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martı́n, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thiéblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei‐Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten - Blood 2022 被引用: 75

  13. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

    著者: Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes, Christoph Groth, Tamás Masszi, Péter Reményi, Eva Wagner-Drouet, Beate Hauptrock, Peter Dreger, Thomas Luft, Wolfgang Bethge, Wichard Vogel, Fabio Ciceri, Jacopo Peccatori, Friedrich Stölzel, Johannes Schetelig, Christian Junghanß, Christina Große-Thie, Mauricette Michallet, Hélène Labussière‐Wallet, Kerstin Schaefer‐Eckart, Sabine Dressler, Goetz Ulrich Grigoleit, Stephan Mielke, Christof Scheid, Udo Holtick, Francesca Patriarca, Marta Medeot, Alessandro Rambaldi, Maria Caterina Micò, Dietger Niederwieser, Georg‐Nikolaus Franke, Inken Hilgendorf, Nils Winkelmann, Domenico Russo, Gèrard Socié, Régis Peffault de Latour, Ernst Holler, Daniel Wolff, Bertram Glaß, Jochen Casper, Gerald Wulf, H Menzel, Nadežda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Sandra Graß, Anna Paola Iori, Jürgen Finke, Fabio Benedetti, Uwe Pichlmeier, Claudia Hemmelmann, Michael Tribanek, Anja Klein, H. A. Mylius, Joachim Baumgart, Monika Dzierżak‐Mietła, Mirosław Markiewicz - The Lancet Haematology 2019 被引用: 154

  14. EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study

    著者: Felix Korell, Olaf Penack, Mike Mattie, Nicholas Schreck, Axel Benner, Julia Krzykalla, Zixing Wang, Michael Schmitt, Lars Bullinger, Carsten Müller‐Tidow, Peter Dreger, Thomas Luft - Frontiers in Immunology 2022 被引用: 65

  15. Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation

    著者: Thomas Luft, Peter Dreger, Aleksandar Radujkovic - Bone Marrow Transplantation 2021 被引用: 77

  16. Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

    著者: Peter Dreger, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Wagner, Gerald Wulf, Reinhardt Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glaß, Claudia D. Baldus, Vladan Vučinić, Dimitrios Mougiakakos, Max S. Topp, Roland Schroers, Daniel Wolff, Simone Thomas, Nicolaus Kröger, Wolfgang Bethge, on behalf of the German Lymphoma Alliance (GLA), the German Stem Cell Transplantation Registry (DRST) - Bone Marrow Transplantation 2022 被引用: 49

  17. Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)

    著者: Susanne Hofmann, Maria‐Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller‐Tidow, Michael Schmitt - Journal of Clinical Medicine 2019 被引用: 108

  18. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial

    著者: Maria‐Luisa Schubert, Anita Schmitt, Angela Hückelhoven‐Krauss, Brigitte Neuber, Alexander Kunz, Philip Waldhoff, Dominik Vonficht, Schayan Yousefian, Lea Jopp‐Saile, Lei Wang, Felix Korell, Anna Keib, Birgit Michels, Dominik Haas, Tim Sauer, Patrick Derigs, Andreas E. Kulozik, Joachim B. Kunz, Petra Pavel, Sascha Laier, Patrick Wuchter, Johann W. Schmier, Gesine Bug, Fabian Lang, Nicola Gökbuget, Jochen Casper, Martin Görner, Jürgen Finke, Andreas Neubauer, Mark Ringhoffer, Denise Wolleschak, Monika Brüggemann, Simon Haas, Anthony D. Ho, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt - Journal of Hematology & Oncology 2023 被引用: 36

  19. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    著者: Nicolaus Kröger, Ernst Holler, Guido Kobbe, Martin Bornhäuser, Rainer Schwerdtfeger, H. Baurmann, Arnon Nagler, Wolfgang Bethge, Matthias Stelljes, Lutz Uharek, Hannes Wandt, Andreas Burchert, Paolo Corradini, Jörg Schubert, Martin Kaufmann, Peter Dreger, Gerald Wulf, Hermann Einsele, Tatjana Zabelina, Hans Michael Kvasnicka, Jürgen Thiele, Ronald Brand, Axel R. Zander, Dietger Niederwieser, Theo M. de Witte - Blood 2009 被引用: 394

  20. Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

    著者: Dietrich W. Beelen, Matthias Stelljes, Péter Reményi, Eva‐Maria Wagner‐Drouet, Peter Dreger, Wolfgang Bethge, Fabio Ciceri, Friedrich Stölzel, Christian Junghanß, Hélène Labussière‐Wallet, Kerstin Schaefer‐Eckart, Goetz Ulrich Grigoleit, Christof Scheid, Francesca Patriarca, Alessandro Rambaldi, Dietger Niederwieser, Inken Hilgendorf, Domenico Russo, Gèrard Socié, Ernst Holler, Bertram Glaß, Jochen Casper, Gerald Wulf, Nadežda Basara, Maria Bieniaszewska, Gernot Stuhler, Mareike Verbeek, Ursula La Rocca, Jürgen Finke, Fabio Benedetti, Uwe Pichlmeier, Anja Klein, Joachim Baumgart, Mirosław Markiewicz - American Journal of Hematology 2022 被引用: 61

  21. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients

    著者: Thomas Luft, Clemens‐Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, Lars Kihm, Matthias Bauer, Peter Dreger, Uta Merle - Frontiers in Immunology 2021 被引用: 61

  22. Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

    著者: Rishika Prasad, Abdur Rehman, Lubna Rehman, Faezeh Darbaniyan, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Eli Zamir, Sabine Schmidt, Tomo Hayase, Chia‐Chi Chang, Lauren K. McDaniel, Ivonne I. Flores, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Michael Wang, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Joel Turner, Fareed Khawaja, Ranran Wu, Jennifer B. Dennison, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Marco L. Davila, Peter Dreger, Felix Korell, Anita Schmitt, Mark R. Tanner, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Samir Hanash, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Johannes F. Fahrmann, Christoph K. Stein‐Thoeringer, Eran Elinav, Michael D. Jain, Eiko Hayase, Robert R. Jenq, Neeraj Saini - Blood 2024 被引用: 50

  23. EASIX for prediction of survival in lower-risk myelodysplastic syndromes

    著者: Almuth Maria Anni Merz, Ulrich Germing, Guido Kobbe, Jennifer Kaivers, Anna Jauch, Aleksandar Radujkovic, Manuela Hummel, Axel Benner, Maximilian Merz, Peter Dreger, Thomas Luft - Blood Cancer Journal 2019 被引用: 69

  24. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    著者: Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall, Albrecht Leo, Patrick Stelmach, Stefan Weber, Johannes Krisam, Lukas Baumann, Jacek Stermann, Uta Merle, Markus A. Weigand, Christian Nußhag, Lars Bullinger, Jens Schrezenmeier, Martin Bornhäuser, Nael Alakel, Oliver Witzke, Timo Wolf, Maria J. G. T. Vehreschild, Stefan Schmiedel, Marylyn M. Addo, Felix Herth, Michael Kreuter, Phil‐Robin Tepasse, Bernd Hertenstein, Mathias Hänel, Anke Morgner, Michael Kiehl, Olaf Hopfer, Mohammad-Amen Wattad, Carl Christoph Schimanski, Cihan Celik, Thorsten Pohle, Matthias Ruhe, Winfried V. Kern, Anita Schmitt, Hanns‐Martin Lorenz, Margarida Souto‐Carneiro, Mary Gaeddert, Niels Halama, Stefan Meuer, Hans‐Georg Kräusslich, Bárbara Müller, Paul Schnitzler, Sylvia Parthé, Ralf Bartenschlager, Martina Gronkowski, Jennifer Klemmer, Michael Schmitt, Peter Dreger, Katharina Kriegsmann, Richard F. Schlenk, Carsten Müller‐Tidow - Nature Cancer 2022 被引用: 62